Annals of the New York Academy of Sciences · 2005 · 19 citations · 20 references
Life SciencesNeurobiologyNeuroscienceBioenergeticsCellular MetabolismMetabolismCellular Energy MetabolismCerebral PhysiologyEnergy MetabolismNeuronal MetabolismNeuroprotectionNicotinamide Adenine Dinucleotide MetabolismAdenosine Triphosphate MetabolismCerebral Blood Flow AlterationsCerebral Blood Flow EffectsCerebral Glucose UtilizationIschemic Neuronal DeathMetabolic CascadeNeuroprotective MechanismsNicotinamide Adenine Dinucleotide (Nad+) Metabolism
The central nervous system depends critically on a regular supply of oxygen and glucose for the formation of adenosine triphosphate (ATP) and the sustenance of its energy metabolism. Consequently, a significant reduction in the supply of oxygen and glucose to neuronal tissue causes an imbalance between the energy supply and demand, inducing the onset of neuronal ischemia and triggering many metabolic cascades leading to irreversible injury and cell death. Nicotinamide (NAm), an essential precursor to nicotinamide adenine dinucleotide (NAD+), which raises brain ATP levels, may improve cerebral blood flow and is neuroprotective against ischemia-induced injury. We therefore chose to examine the metabolic and electrophysiologic/functional effects of NAm (0.1 mM, 1.0 mM, 10.0 mM) under normal, control, and ischemic conditions, as well as following the early stages of reperfusion ("return-to-control" conditions) using an in vitro rabbit retina model where blood flow effects are excluded. Under nonischemic, control conditions, the protective concentration of NAm (10.0 mM) increased glucose utilization (34%, P < 0.01) and decreased lactate production (44%, P < 0.01), but had no significant effect on electrophysiologic function. After 2 h of ischemia, glucose utilization was significantly decreased (41%, P < 0.01) and lactate production was unaffected by NAm (10 mM). Following 3 h of "reperfusion", NAm (10 mM) significantly improved glucose utilization (217%, P < 0.01), lactate production (40%, P < 0.01), and electrophysiologic function (264%, P < 0.01) relative to controls. Thus, the functional neuroprotective effects of NAm may be independent of blood flow effects, but related, at least in part, to its improvement of tissue glucose utilization and lactate production.
20
Pathophysiology and treatment of focal cerebral ischemia
Bo K. Siesjö · Journal of neurosurgery · 1992 · 1.3K citations
Medicine, Neurology, Neuroscience +16
Lori K. Klaidman, María Paz Morales, Seyha Kem et al. · Pharmacology · 2003 · 120 citations